DMAA safety data “full of gaps”
date:Aug 23, 2012
cardiovascular effects are precipitated which range from shortness of breath to tightening of the chest or a possible myocardial infarction. In addition, a significant acute increase in blood pressure can increase the risk of cerebral haemorrhage.

The agency noted the US Food and Drug Administration (FDA) had received 42 adverse event reports, including cardiac disorders, nervous system disorders, psychiatric disorders and death.

But it acknowledged,Details on the reports, for example regardi
4/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/15 19:41